Archive for the 'Health' Category

Dr. Mark McKenna, Entrepreneur & Revolutionary In Medicine

Yazan: spcblog | 05 January 2018 | No Comments
Categories: Health, Investment

Over the past few decades, we have seen some pretty significant changes in many industries through regulation as well as consumer demand. The ever changing markets of economy allow for entrepreneurial endeavors to bear fruits for those who have the intellect and the courage to ride to the occasion and follow through with their dreams. […]

Oncotarget is Instrumental in Helping to Make Strides Against Thyroid Cancer

Yazan: spcblog | 26 December 2017 | No Comments
Categories: Health

There is a medical and oncology journal that surfaced some years ago called Oncotarget. What makes it special is that Oncotarget is almost entirely devoted to treatment of cancer and cancer research, with a few other medical subjects introduced from time to time. Oncotarget is the brain child of the two editors-in-chief are Mikhail Blagosklonny […]

Clinical Pathways Can Now Be Accessed In All the Five Cancer Treatment Centers of America Hospitals

Yazan: spcblog | 17 November 2017 | No Comments
Categories: Cancer Treatment, Health

Basic Information about CTCA Cancer Treatment Centers of America (CTCA) was founded in the year 1998. It has a board of certified oncologists who have undergone extensive training and have top-notch expertise when it comes to cancer treatments. The cancer experts know about cancers such as breast, colorectal, throat, lung, ovarian, prostate, pancreatic, and others. […]

Oncotarget Contributes To the Medical Field through Research

Yazan: spcblog | 27 September 2017 | No Comments
Categories: Health, Health Care

It is a weekly peer reviewed medical journal that publishes articles on aspects of oncology, endocrinology, pathology, age related diseases, physiology, cancer and immunology. Oncotarget articles can be openly accessed. The research journal was established in 2010 and is normally published by Impact Journals. Its chief editors are Mikhail Blagosklonny and Andrei Gudkov. Oncotarget on; […]